Findings

What do systematic reviews say?

34 questions · 34 findings · 22 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 18 · 52.9%GRADE not reported 3 · 8.8%Very low 1 · 2.9%Low 2 · 5.9%Moderate 10 · 29.4%High 0 · 0%

Surgical interventions (exploration and decompression / external neurolysis, internal neurolysis, neurorrhaphy / direct repair, neuroma excision, anastomosis, autologous or allograft nerve grafting or tubulization) vs non‐surgical treatment

Quality of life · Adults with symptomatic mild to moderate knee osteoarthritis defined as knee pain and radiographic evidence of non‐end stage…

The review found no eligible studies for this question.

1 finding from 1 review

Surgical interventions for symptomatic mild to moderate knee osteoarthritis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prebiotics and anti‐inflammatory therapy vs anti‐inflammatory therapy

Quality of life · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Inulin and oligofructose 15 g vs inulin and oligofructose 7.5 g daily

Quality of life · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs standard plasma

Quality of life, · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs placebo or usual care

Quality of life, · individuals with moderate to severe disease

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 483 participants
Low

RBD‐specific polyclonal F(ab') 2 fragments of equine antibodies (EpAbs) vs saline placebo

Quality of life · individuals with moderate or severe COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Hyperimmune immunoglobulin for people with COVID‐19 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hyperimmune immunoglobulin from human plasma vs saline placebo

Quality of life · individuals with moderate or severe COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Hyperimmune immunoglobulin for people with COVID‐19 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Quality of life · people with dementia and mild to moderate pain

1 finding from 1 review

Algorithm‐based pain management for people with dementia in nursing homes 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Hydromorphone vs morphine

Quality of life · people with moderate to severe cancer pain

The review found no eligible studies for this question.

1 finding from 1 review

Hydromorphone for cancer pain 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hydromorphone vs fentanyl

Quality of life · people with moderate to severe cancer pain

The review found no eligible studies for this question.

1 finding from 1 review

Hydromorphone for cancer pain 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hydromorphone vs oxycodone

Quality of life · people with moderate to severe cancer pain

The review found no eligible studies for this question.

1 finding from 1 review

Hydromorphone for cancer pain 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bamlanivimab vs placebo

Quality of life · hospitalised individuals with COVID‐19 (moderate to severe disease)

The review found no eligible studies for this question.

1 finding from 1 review

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Casirivimab/imdevimab vs usual care

Quality of life · hospitalised individuals with COVID‐19 (moderate to severe disease)

The review found no eligible studies for this question.

1 finding from 1 review

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Souvenaid vs placebo

Quality of life, · Apathy in people with mild‐to‐moderate Alzheimer's disease

1 finding from 1 review

Souvenaid for Alzheimer's disease 2020 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Summary of findings table ‐ Cognitive rehabilitation vs no treatment

Quality of life · Treating patients with traumatic brain injury

1 finding from 1 review

Cognitive rehabilitation for adults with traumatic brain injury to improve occupational outcomes 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 98 participants
Low

High‐dose corticosteroids vs moderate‐dose or no corticosteroids

Quality of life · adults with metastatic extradural spinal cord compression (without peptic ulceration or infection; mixed prognosis)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of metastatic extradural spinal cord compression in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tiotropium vs ipratropium

Quality of life ( · chronic obstructive pulmonary disease (COPD). Participants in included studies had an average baseline FEV1 of around 40% predicted and…

1 finding from 1 review

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 535 participants
Moderate

Summary of findings table ‐ Cognitive rehabilitation vs inactive control

QoL · people with mild‐to‐moderate dementia (at medium‐term follow‐up)

1 finding from 1 review

Cognitive rehabilitation for people with mild to moderate dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 783 participants
Moderate

Summary of findings table ‐ Cognitive rehabilitation vs inactive control

QoL · people with mild‐to‐moderate dementia (at the end of therapy)

1 finding from 1 review

Cognitive rehabilitation for people with mild to moderate dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 853 participants
Moderate

Summary of findings table ‐ Cognitive rehabilitation vs inactive control

Quality of life: psychological (care partner self‐report) · people with mild‐to‐moderate dementia (at medium‐term follow‐up)

1 finding from 1 review

Cognitive rehabilitation for people with mild to moderate dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 437 participants
Moderate